SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study.

导出 LinkOut

翻译打印收藏纠错

作者： Aino,Latva-Rasku ^[1] ; Eleni,Rebelos ^[2] ; Jouni,Tuisku ^[2] ; Richard,Aarnio ^[2] ; Achol,Bhowmik ^[2] ; Helmi,Keskinen ^[2] ; Sanna,Laurila ^[3] ; Minna,Lahesmaa-Hatting ^[2] ; Laura,Pekkarinen ^[1] ; Henrik,Isackson ^[4] ; Anna K,Kirjavainen ^[5] ; Jukka,Koffert ^[2] ; Kerstin,Heurling ^[6] ; Lauri,Nummenmaa ^[7] ; Ele,Ferrannini ^[8] ; Jonas,Oldgren ^[9] ; Jan,Oscarsson ^[10] ; Pirjo,Nuutila ^[1]

作者单位： Turku PET Centre, University of Turku, Turku, Finland.;Department of Endocrinology, Turku University Hospital, Turku, Finland. ^[1] Turku PET Centre, University of Turku, Turku, Finland. ^[2] Turku PET Centre, University of Turku, Turku, Finland.;Heart Center, Turku University Hospital, Turku, Finland. ^[3] Clinical Physiology and Cardiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.;Integrative Physiology, Medical Cell Biology, Uppsala University Hospital, Uppsala, Sweden. ^[4] Radiopharmaceutical Chemistry Laboratory, Turku PET Centre, University of Turku, Turku, Finland. ^[5] Antaros Medical AB, Gothenburg, Sweden. ^[6] Turku PET Centre, University of Turku, Turku, Finland.;Department of Psychology, University of Turku, Turku, Finland. ^[7] National Research Council Institute of Clinical Physiology, Pisa, Italy. ^[8] Clinical Physiology and Cardiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.;Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden. ^[9] Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden. ^[10]